4.7 Review

New evidence on the management of Lewy body dementia

Journal

LANCET NEUROLOGY
Volume 19, Issue 2, Pages 157-169

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(19)30153-X

Keywords

-

Funding

  1. UK NIHR [DTC-RPPG-0311-12001]
  2. MRC [G1100540] Funding Source: UKRI

Ask authors/readers for more resources

Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body dementia, are common neurodegenerative conditions. Patients with Lewy body dementia present with a wide range of cognitive, neuropsychiatric, sleep, motor, and autonomic symptoms. Presentation varies between patients and can vary over time within an individual. Treatments can address one symptom but worsen another, which makes disease management difficult. Symptoms are often managed in isolation and by different specialists, which makes high-quality care difficult to accomplish. Clinical trials and meta-analyses now provide an evidence base for the treatment of cognitive, neuropsychiatric, and motor symptoms in patients with Lewy body dementia. Furthermore, consensus opinion from experts supports the application of treatments for related conditions, such as Parkinson's disease, for the management of common symptoms (eg, autonomic dysfunction) in patients with Lewy body dementia. However, evidence gaps remain and future dinical trials need to focus on the treatment of symptoms specific to patients with Lewy body dementia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available